Contact Support: 512-708-4678


New Course Alerts and CME News

Renal Transplant Individualized Care: Determining CNI Dosing and Managing Side Effects
Therapeutic Dashboard

Jun 11, 2016 - Jun 11, 2017

Calcineurin inhibitors (CNIs) are essential to graft survival post-renal transplant. Unfortunately, despite proven efficacy, these drugs are associated with side effects that may affect patient adherence. This short activity includes a discussion of CNI side effects and strategies for appropriate assessment of adherence and dosing to balance efficacy and safety. 

Alexander C. Wiseman, MD, FACP 
Professor of Medicine, Division of Renal Diseases and Hypertension Medical Director, Kidney and Pancreas Transplant Programs University of Colorado School of Medicine Aurora, CO

Upon completion of the educational activity, participants should be able to: 

  • Describe the toxicities most likely to occur with tacrolimus and cyclosporine administration, and the first-line intervention to address toxicity 

  • List three questions for assessing patient adherence

This activity is intended for nephrologists, transplant surgeons, general internists, nurses, nurse practitioners, pharmacists, and other healthcare professionals with a focus on kidney transplants.

There is no schedule for this activity.

There is no fee to register for this activity.

Please click here to register.

AKH Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Physician Assistants 
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME. 

AKH, Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. AKH, Inc., Advancing Knowledge in Healthcare approves this knowledge- based activity for 0.25 contact hour(s) (0.025 CEUs). UAN 0077-0000-16-058-H04-P. Initial Release Date: June 11, 2016. 

AKH, Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is awarded 0.25 Contact Hours. 

Nurse Practitioners 
AKH, Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider Number: 030803. This program is accredited for 0.25 contact hour(s) which includes 0 hour(s) of pharmacology. Program ID #21633-2. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standard